X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells With Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Role of X-Linked Inhibitor of Apoptosis in Breast Cancer

2008English

The Cyclin-Dependent Kinase Inhibitor SNS-032 Induces Apoptosis in Breast Cancer Cells via Depletion of McL-1 and X-Linked Inhibitor of Apoptosis Protein and Displays Antitumor Activity in Vivo

International Journal of Oncology
Cancer ResearchOncology
2014English

X-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibits Caspase-3 and -7 in Distinct Modes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Associated With Suppression of Inhibitor of Apoptosis Family Protein Expression

Cancer Letters
Cancer ResearchOncology
2013English

X-Linked Inhibitor of Apoptosis Protein as a Therapeutic Target in Metastatic Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2008English

BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy